10-Q: AdaptHealth Corp. Reports Mixed Q1 2024 Results Amidst Revenue Growth and Increased Expenses

AdaptHealth Corp. saw a revenue increase in Q1 2024, but also experienced a net loss due to increased costs and a goodwill impairment.

Summary

• AdaptHealth Corp. reported a net revenue of $792.5 million for the first quarter of 2024, a 6.4% increase compared to $744.6 million in the same period last year.
• The company experienced a net loss of $2.1 million attributable to AdaptHealth Corp., a significant decrease from the $15.7 million net income in Q1 2023.
• The increase in revenue was driven by non-acquired growth of $46.1 million and acquisitions contributing $1.8 million.
• The company's sleep business revenue increased by 4.0%, while respiratory and diabetes segments saw increases of 1.6% and 2.0% respectively.
• Cost of net revenue increased by 3.1% to $675.7 million, primarily due to higher product costs, labor expenses, and patient equipment depreciation.
• General and administrative expenses rose by 1.8% to $48.4 million, influenced by higher professional fees and incentive compensation.
• A goodwill impairment charge of $6.5 million was recorded due to an immaterial business disposal.
• The company's operating income increased significantly to $50.5 million from $26.2 million in the prior year.
• The company's free cash flow was negative $38.9 million for the quarter, compared to a positive $51.1 million in the same period last year, primarily due to changes in operating assets and liabilities and the impact of a cyber security incident at Change Healthcare.

Sentiment

Score: 4

Explanation: The document presents mixed results with revenue growth offset by a net loss, negative free cash flow, and ongoing legal and operational challenges. The sentiment is cautiously negative due to the financial underperformance and identified risks.

Positives

• Net revenue increased by 6.4% year-over-year, driven by both organic growth and acquisitions.
• Operating income increased significantly to $50.5 million from $26.2 million in the prior year.
• The company's sleep, respiratory and diabetes businesses all experienced revenue growth.
• The company has taken steps to remediate previously identified material weaknesses in internal control over financial reporting.

Negatives

• The company reported a net loss of $2.1 million, a significant decrease from the $15.7 million net income in Q1 2023.
• Free cash flow was negative $38.9 million, a decrease from positive $51.1 million in the same period last year.
• A goodwill impairment charge of $6.5 million was recorded.
• The company experienced payment collection delays due to a cyber security incident at Change Healthcare.
• The company borrowed $75 million under its revolving credit facility to fund operating cash requirements.

Risks

• The company faces risks related to competition, economic factors, and changes in laws and regulations.
• Inflationary pressures are increasing costs for materials, labor, and transportation, which may impact profitability.
• The company's financial results may be affected by the outcome of ongoing legal proceedings.
• The company's internal controls over financial reporting have material weaknesses that need to be remediated.
• The company is subject to a civil investigative demand related to potential false claims, which could have a material adverse effect.

Future Outlook

The company believes its operating cash flows, existing cash, and available credit will be sufficient to fund operations and growth strategies for at least the next twelve months. The company may seek additional equity or debt financing for acquisitions.

Management Comments

• Management is working to remediate material weaknesses in internal control over financial reporting.
• Management believes that the issues relating to the claims processing activity resulting from the Change Healthcare incident will be resolved and that the company's operating cash flows will normalize during the second quarter of 2024.

Industry Context

The company operates in the home healthcare equipment and medical supplies industry, which is experiencing growth due to an aging population and increasing demand for home-based care. The company's performance is influenced by reimbursement policies of Medicare, Medicaid, and commercial insurance payors.

Comparison to Industry Standards

• AdaptHealth's revenue growth of 6.4% is within the range of growth seen by other major players in the home medical equipment sector, such as Lincare and Apria Healthcare, though specific comparisons are difficult without detailed competitor financials.
• The company's adjusted EBITDA margin of 20.0% is comparable to industry averages, but the net loss is a concern compared to peers who are generally profitable.
• The negative free cash flow is a significant deviation from industry norms, which typically see positive cash flow from operations, and is largely attributed to the Change Healthcare cyber incident and related payment delays.
• The company's reliance on third-party software providers for revenue transactions is a common practice in the industry, but the material weaknesses identified in internal controls highlight a need for stronger oversight and risk management compared to best practices.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in a securities class action lawsuit, which has a proposed settlement.
• The company is involved in a shareholder derivative lawsuit, which has a proposed settlement.
• The company is subject to a civil investigative demand related to potential false claims.
• The company is involved in a class action complaint related to allegations of false and misleading statements regarding organic growth in its diabetes business.
• The company is involved in a shareholder derivative complaint related to the allegations in the Allegheny County Complaint.

Related Party Transactions

• The company has transactions with a vendor in which an executive officer and shareholder has a less than 1% equity interest.
• A director of the company serves on the board of directors of a third-party payor that does business with the company.
• A director of the company is an employee of a beneficial owner of more than 5% of the company's common stock, which is also a minority shareholder of a vendor that provides medical equipment and supplies to the company.
• A former regional manager of the company is a shareholder of a business which provides contract labor to the company.

Stakeholder Impact

• Shareholders are impacted by the net loss, negative free cash flow, and ongoing legal proceedings.
• Employees are impacted by the company's cost-saving measures and changes in management.
• Customers may be impacted by the company's operational challenges and potential changes in service.
• Suppliers may be impacted by the company's financial performance and potential changes in purchasing practices.
• Creditors are impacted by the company's debt levels and financial performance.

Next Steps

• The company will continue to remediate material weaknesses in internal control over financial reporting.
• The company expects to resolve issues related to the Change Healthcare cyber security incident and normalize operating cash flows during the second quarter of 2024.
• The company will seek final court approval for the proposed settlements in the securities class action and shareholder derivative lawsuits.
• The company will continue to defend against the allegations in the Allegheny County Complaint and the Wu Derivative Complaint.

Key Dates

Keywords

AdaptHealth, Home Medical Equipment, HME, Sleep Therapy, Diabetes, Respiratory, Revenue, EBITDA, Financial Results, Healthcare, Medical Supplies, Cyber Security, Legal Proceedings